Trials / Completed
CompletedNCT04574830
Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
Clinical Survey Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Ultragenyx Pharmaceutical Inc · Industry
- Sex
- All
- Age
- 5 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate potential biomarkers of GSD III.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No Intervention |
Timeline
- Start date
- 2020-11-23
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2020-10-05
- Last updated
- 2022-09-13
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04574830. Inclusion in this directory is not an endorsement.